You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 70677-0143


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70677-0143

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

70677-0143 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 70677-0143

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as a universal product identifier for human drugs in the United States. This code identifies the labeler, the product, and the trade package size[4].

NDC Structure

The NDC is a 10-digit number, typically configured in one of three formats: 4-4-2, 5-3-2, or 5-4-1. The first segment is the labeler code, assigned by the FDA; the second segment is the product code, which identifies the strength, dosage form, and formulation; and the third segment is the package code, which identifies the package size and type[4].

Market Analysis for NDC 70677-0143

Drug Identification

To conduct a market analysis, the first step is to identify the drug associated with the NDC 70677-0143. This involves checking the FDA's National Drug Code Directory or other pharmaceutical databases. The NDC Directory contains information on active and certified finished and unfinished drugs, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged and relabeled drugs[1].

Market Trends

Market trends for prescription drugs can be influenced by several factors, including the prevalence of the condition the drug treats, competition from generic or brand-name alternatives, and regulatory changes.

  • Utilization and Cost Trends: Drugs that are commonly prescribed for chronic conditions such as high cholesterol, hypothyroidism, high blood pressure, asthma, depression, heartburn, and epilepsy tend to have stable or increasing demand. For instance, a report by the Maine Health Data Organization highlighted that drugs for these conditions were among the top utilized and had significant year-over-year cost increases[3].

Price Dynamics

The pricing of drugs is complex and involves various stakeholders, including manufacturers, wholesalers, pharmacies, and pharmacy benefit managers (PBMs).

  • Wholesale Acquisition Cost (WAC) and Average Wholesale Price (AWP): The WAC and AWP are key metrics in drug pricing. The WAC is the list price set by the manufacturer, while the AWP is a benchmark price used for reimbursement. For brand drugs, the AWP often increases at a rate similar to the WAC, and PBMs receive rebates that can offset costs to payers[3].

  • Rebates and Discounts: Rebates from manufacturers to PBMs can significantly impact the net cost of drugs. For brand drugs, these rebates can be substantial, averaging around 13.27% of the WAC. However, for generic drugs, rebates are typically much lower[3].

Price Projections for NDC 70677-0143

Historical Pricing Data

To project future prices, it is essential to analyze historical pricing data for the drug. This includes looking at past price increases or decreases, as well as any changes in the drug's market category (e.g., from brand to generic).

  • Price Increase Trends: The percentage of drugs with price increases has been decreasing, but the number of drugs with price increases has been gradually increasing over the past few years. The average percent increase for price increases has also been above the consumer price index (CPI-U)[3].

Competitive Landscape

The competitive landscape plays a crucial role in price projections. If the drug faces competition from generic or other brand-name drugs, this could impact pricing.

  • Generic Competition: Generic drugs often lead to significant price decreases for the original brand-name drug. For instance, multisource generic drugs had an average percent decrease of 49.21% in 2022, leading to a substantial reduction in payer-paid amounts[3].

Regulatory Factors

Regulatory changes can also influence drug prices. For example, changes in FDA regulations or new laws affecting pharmaceutical pricing can impact the market.

  • FDA Regulations: The FDA's requirements for drug listing and the inclusion of compounded drugs in the NDC Directory can affect how drugs are marketed and priced. Outsourcing facilities, for instance, may assign NDCs to their compounded human drug products, which can influence pricing transparency[1].

Key Factors Influencing Price Projections

  • Demand and Supply: Changes in demand due to epidemiological trends or supply chain disruptions can impact prices.
  • Reimbursement Policies: Changes in reimbursement policies by payers, including Medicare and Medicaid, can also affect drug prices.
  • Innovation and New Entrants: The introduction of new drugs or formulations can alter the competitive landscape and pricing strategies.

Example of Price Analysis

For a drug like the one identified by NDC 70677-0143, if it is a brand drug with significant market share and limited generic competition, the price might be more stable or see moderate increases. Here is an illustrative example:

  • Current Pricing: Assume the current WAC for the drug is $100 per unit.
  • Historical Trends: If the drug has seen an average annual price increase of 10%, similar to the overall trend for brand drugs[3].
  • Projected Price: For the next year, the projected price could be $110 per unit, assuming the same rate of increase.

Conclusion

Market analysis and price projections for a drug identified by its NDC require a comprehensive understanding of the drug's market dynamics, historical pricing trends, competitive landscape, and regulatory environment.

Key Takeaways

  • NDC Structure: The NDC is a unique identifier that includes the labeler code, product code, and package code.
  • Market Trends: Drugs for chronic conditions tend to have stable or increasing demand.
  • Price Dynamics: WAC, AWP, and rebates play crucial roles in drug pricing.
  • Competitive Landscape: Generic competition and new entrants can significantly impact pricing.
  • Regulatory Factors: FDA regulations and reimbursement policies can influence drug prices.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a human drug.

Q: How often are drug listings updated in the NDC Directory? A: Drug listings are updated daily, and registered establishments must update their drug listing data in June and December of each year[1].

Q: What factors influence the pricing of prescription drugs? A: Pricing is influenced by demand and supply, competition, regulatory changes, and reimbursement policies.

Q: How do rebates affect the net cost of brand drugs? A: Rebates from manufacturers to PBMs can significantly offset the costs to payers, often averaging around 13.27% of the WAC for brand drugs[3].

Q: What happens to prices when a brand drug faces generic competition? A: Prices typically decrease significantly, with generic drugs often leading to a reduction in payer-paid amounts by up to 49.21% or more[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price - Missouri Department of Social Services
  3. Maine Health Data Organization Rx Transparency Report - Maine Health Data Organization
  4. National Drug Code Database Background Information - FDA
  5. Latest drug prices and trends for NDC 5167 - DrugPatentWatch

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.